BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6420959)

  • 21. Ratios of T lymphocyte subpopulations predict survival of cadaveric renal allografts in adult patients on low dose corticosteroid therapy.
    Van Es A; Tanke HJ; Baldwin WM; Oljans PJ; Ploem JS; Vanes LA
    Clin Exp Immunol; 1983 Apr; 52(1):13-20. PubMed ID: 6345032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interest in and limitations of monoclonal anti-T-cell antibodies for the follow-up of renal transplant patients.
    Chatenoud L; Chkoff N; Kreis H; Bach JF
    Transplantation; 1983 Jul; 36(1):45-50. PubMed ID: 6191417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monoclonal antibody OKT3 therapy in pediatric kidney transplant recipients.
    Leone MR; Barry JM; Alexander SR; Melvin T; Striegel J; Reller K; Henell KR; Kimball J; Funnell MB; Goldstein G
    J Pediatr; 1990 May; 116(5):S86-91. PubMed ID: 2139465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prophylactic use of OKT3 monoclonal antibody in cadaver kidney recipients. Utilization of OKT3 as the sole immunosuppressive agent.
    Vigeral P; Chkoff N; Chatenoud L; Campos H; Lacombe M; Droz D; Goldstein G; Bach JF; Kreis H
    Transplantation; 1986 Jun; 41(6):730-3. PubMed ID: 3520988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antithymocyte globulin in cadaver kidney transplantation: a randomized trial based on T-cell monitoring.
    Kreis H; Mansouri R; Descamps JM; Dandavino R; N'Guyen AT; Bach JF; Crosnier J
    Kidney Int; 1981 Mar; 19(3):438-44. PubMed ID: 7017244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of rabbit antithymocyte serum and OKT3 as prophylaxis against renal allograft rejection.
    Cole EH; Cattran DC; Farewell VT; Aprile M; Bear RA; Pei YP; Fenton SS; Tober JA; Cardella CJ
    Transplantation; 1994 Jan; 57(1):60-7. PubMed ID: 8291115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are there non-steroid-dependent rejection episodes?
    Crosnier J; Kreis H; Descamps JM; Mansouri R
    Proc Eur Dial Transplant Assoc; 1980; 17():391-5. PubMed ID: 7017680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcineurin inhibitor-free immunosuppression based on antithymocyte globulin and mycophenolate mofetil in cadaveric kidney transplantation: results after 5 years.
    Grinyó JM; Gil-Vernet S; Cruzado JM; Caldés A; Riera L; Serón D; Rama I; Torras J
    Transpl Int; 2003 Nov; 16(11):820-7. PubMed ID: 12879230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allografts.
    Soulillou JP; Cantarovich D; Le Mauff B; Giral M; Robillard N; Hourmant M; Hirn M; Jacques Y
    N Engl J Med; 1990 Apr; 322(17):1175-82. PubMed ID: 2157982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of OKT3 and antithymocyte globulin as induction immunosuppressive agents in renal transplantation.
    Kitabayashi K; Munn SR; Sterioff S
    Transplant Proc; 1996 Jun; 28(3):1973-5. PubMed ID: 8658964
    [No Abstract]   [Full Text] [Related]  

  • 31. One-month prophylactic use of OKT3 in cadaver kidney transplant recipients.
    Debure A; Chkoff N; Chatenoud L; Lacombe M; Campos H; Noël LH; Goldstein G; Bach JF; Kreis H
    Transplantation; 1988 Mar; 45(3):546-53. PubMed ID: 3279578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Corticosteroid avoidance in adult kidney transplant recipients under rabbit anti-T-lymphocyte globulin, mycophenolate mofetil and delayed cyclosporine microemulsion introduction.
    Cantarovich D; Rostaing L; Kamar N; Saint-Hillier Y; Ducloux D; Mourad G; Garrigue V; Wolf P; Ellero B; Cassuto E; Albano L; Soulillou JP;
    Transpl Int; 2010 Mar; 23(3):313-24. PubMed ID: 19843296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extended treatment with antithymocyte globulin (ATGAM) in renal allograft recipients.
    Wechter WJ; Morrell RM; Bergan J; Rosenberg JC; Turcotte J; Schultz JR
    Transplantation; 1979 Nov; 28(5):365-7. PubMed ID: 392832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. OKT3 prophylaxis in cadaveric kidney transplant recipients with delayed graft function.
    Cohen DJ; Benvenisty AI; Cianci J; Hardy MA
    Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):19-27. PubMed ID: 2510507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rabbit antithymocyte globulin versus basiliximab in renal transplantation.
    Brennan DC; Daller JA; Lake KD; Cibrik D; Del Castillo D;
    N Engl J Med; 2006 Nov; 355(19):1967-77. PubMed ID: 17093248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antilymphocyte induction immunosuppression in the post-Minnesota anti-lymphocyte globulin era: incidence of renal dysfunction and delayed graft function. A single center experience.
    Malinow L; Walker J; Klassen D; Oldach D; Schweitzer E; Bartlett ST; Weir MR
    Clin Transplant; 1996 Jun; 10(3):237-42. PubMed ID: 8826659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation.
    Gaber AO; First MR; Tesi RJ; Gaston RS; Mendez R; Mulloy LL; Light JA; Gaber LW; Squiers E; Taylor RJ; Neylan JF; Steiner RW; Knechtle S; Norman DJ; Shihab F; Basadonna G; Brennan DC; Hodge EE; Kahan BD; Kahan L; Steinberg S; Woodle ES; Chan L; Ham JM; Schroeder TJ
    Transplantation; 1998 Jul; 66(1):29-37. PubMed ID: 9679818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prophylactic therapy for rejection after cardiac transplantation. A comparison of rabbit antithymocyte globulin and OKT3.
    Kirklin JK; Bourge RC; White-Williams C; Naftel DC; Thomas FT; Thomas JM; Phillips MG
    J Thorac Cardiovasc Surg; 1990 Apr; 99(4):716-24. PubMed ID: 2108282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quadruple immunosuppression: comparison of OKT3 and Minnesota antilymphocyte globulin.
    Light JA; Khawand N; Aquino A; Ali A; Korb S
    Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):10-3. PubMed ID: 2510505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biocompatible dialysis membranes and acute renal failure: a study in post-operative acute tubular necrosis in cadaveric renal transplant recipients.
    Valeri A; Radhakrishnan J; Ryan R; Powell D
    Clin Nephrol; 1996 Dec; 46(6):402-9. PubMed ID: 8982557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.